MaxCyte will be attending the 30th annual meeting of the Japan Society of Gene and Cell Therapy as well as having a workshop.
Explore potential pathways to innovations that will change society and learn about gene therapy research.
Featured presentation
Wednesday, July 17, 2024, from 11:40 am to 12:40 pm (JT)
Development of a non-viral gene delivery platform for CAR T manufacturing
This talk will focus on a comparison between viral and non-viral platforms for the development of a GD2 CAR T manufacturing process. We will demonstrate process comparability and the feasibility of a non-viral process for CAR T manufacturing.